What is Nilo Therapeutics?
Nilo Therapeutics, headquartered in New York, New York, is a biotechnology firm dedicated to advancing treatments for autoimmune and inflammatory diseases. The company's focus on these complex conditions positions it within a critical segment of the healthcare market, aiming to address unmet medical needs through innovative therapeutic approaches.
How much funding has Nilo Therapeutics raised?
Nilo Therapeutics has raised a total of $101M across 1 funding round:
Other Financing Round
$101M
Other Financing Round (2025): $101M, investors not publicly disclosed
What's next for Nilo Therapeutics?
The recent major strategic investment signals a pivotal phase for Nilo Therapeutics, likely enabling accelerated research and development, clinical trial progression, and potential market expansion. This infusion of capital is expected to bolster the company's efforts in bringing novel therapies to patients suffering from autoimmune and inflammatory conditions, reinforcing its strategic position in the competitive biotech landscape.
See full Nilo Therapeutics company page
